EED in complex with PRC2 allosteric inhibitor compound 8

Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy

hEED,WD protein associating with integrin cytoplasmic tails 1,WAIT-1

ENX-1,Enhancer of zeste homolog 2,Lysine N-methyltransferase 6

0.1 M Tris, 16% PEG 8000, 10 mM beta-Nicotinamide mononucleotide

Polycomb protein EED, Histone-lysine N-methyltransferase EZH2 (E.C.2.1.1.43)

EED, PRC2, inhibitor, Transferase-Transferase Inhibitor complex